Related Experiment Video
Updated: Aug 12, 2026
08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
[Rationale and methods for high dose chemotherapy in oncology]
1Kliniki Hematologii Collegium Medicum, Uniwersytetu Jagiellońskiego w Krakowie. alekskot@endo.cm-uj.krakow.pl
Przeglad Lekarski
|September 24, 1999
Summary
Intensive chemotherapy with autologous stem cell transplantation improves cancer treatment. Autologous peripheral blood stem cell transplantation (auto-PBSCT) offers a safer, faster recovery compared to traditional methods.
Area of Science:
- Oncology
- Hematology
- Pharmacology
Context:
- Current antineoplastic treatments require optimization due to the lack of novel, highly effective cytotoxic drugs.
- Chemosensitive tumors benefit from intensive, short-term induction and adjuvant chemotherapy regimens.
- Treatment delays, dose reductions, or improper regimens can lead to drug resistance and treatment failure.
Purpose:
- To enhance antineoplastic treatment strategies using existing drugs and methods.
- To investigate the role of high-dose chemotherapy with autologous stem cell transplantation in improving cancer therapy outcomes.
Summary:
- High-dose chemotherapy (HDCT) with autologous hemopoietic cell transplantation enables dose escalation of cytostatics with manageable non-hematological toxicity.
- Autologous peripheral blood stem cell transplantation (auto-PBSCT) is a widely adopted method for HDCT, demonstrating equivalent efficacy to autologous bone marrow transplantation (ABMT).
- Auto-PBSCT presents advantages over ABMT, including enhanced safety, accelerated hemopoietic recovery, and reduced hospitalization periods.
Impact:
- Optimized chemotherapy regimens can improve patient outcomes and overcome treatment resistance.
- Autologous stem cell transplantation, particularly auto-PBSCT, represents a significant advancement in intensive cancer therapy.
- The findings support the broader implementation of auto-PBSCT for patients with chemosensitive tumors, improving treatment efficacy and patient experience.
Related Concept Videos
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:24Rational Dosage Regimen: Maintenance Dose and Loading Dose
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady state,...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady state,...
01:21Dose Size and Dosing Frequency: Determination Methods
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
01:25Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...